AU Patent

AU2008236993A1 — Method of treating brain cancer

Assigned to Myrexis Inc · Expires 2008-10-16 · 18y expired

What this patent protects

Patent listed against chembl-chembl428647.

Drugs covered by this patent

chembl-chembl428647 (PACLITAXEL)

Patent Metadata

Patent number: AU2008236993A1
Jurisdiction: AU
Classification: —
Expires: 2008-10-16
Drug substance claim: No
Drug product claim: No
Assignee: Myrexis Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.